Start free trial
Trending New Genres Authors
EnglishEnglish
EspañolSpanish
简体中文Chinese
繁體中文Chinese (Traditional)
FrançaisFrench
DeutschGerman
日本語Japanese
PortuguêsPortuguese
ItalianoItalian
한국어Korean
РусскийRussian
NederlandsDutch
العربيةArabic
PolskiPolish
हिन्दीHindi
Tiếng ViệtVietnamese
SvenskaSwedish
ΕλληνικάGreek
TürkçeTurkish
ไทยThai
ČeštinaCzech
RomânăRomanian
MagyarHungarian
УкраїнськаUkrainian
IndonesiaIndonesian
DanskDanish
SuomiFinnish
БългарскиBulgarian
עבריתHebrew
NorskNorwegian
HrvatskiCroatian
CatalàCatalan
SlovenčinaSlovak
LietuviųLithuanian
SlovenščinaSlovenian
СрпскиSerbian
EestiEstonian
LatviešuLatvian
فارسیPersian
മലയാളംMalayalam
தமிழ்Tamil
اردوUrdu
Searching...
SoBrief
Curing the Incurable

Curing the Incurable

Vitamin C, Infectious Diseases, and Toxins
A vitamin C treatment claim spans polio, poisoning, and a crucial question: what counts as proof?
by Thomas E. Levy 2002 518 pages
4.39
158 ratings
Listen
Immersive
V2.3
Amazon Kindle Audible
Try Full Access for 3 Days
Unlock listening & more!
Continue

Key Takeaways

Levy argues high-dose vitamin C can cure infections deemed incurable

The central claim. Thomas Levy presents vitamin C not merely as a nutrient that prevents scurvy, but as a potentially powerful treatment for infections and poisonings. He argues that sufficiently large, frequent doses can sometimes reverse illnesses for which conventional care offers mainly symptom relief. Polio and viral hepatitis are his flagship examples, alongside measles, encephalitis, tetanus, and many forms of poisoning. The book's argument rests on older laboratory work, case reports, and clinicians' experiences, especially those of Frederick Klenner.

A claim, not a consensus. Levy goes further than the evidence he assembles can securely establish. His sweeping language about cures, prevention, and vaccines should be read as the author's position, not as a settled medical conclusion. The book's practical value is its invitation to examine vitamin C research. Its central medical claims require stronger testing before they can guide treatment.

Analysis

The book's appeal comes from a clean, testable proposition: a familiar nutrient might have effects far beyond preventing deficiency. That makes the claims worth examining rather than dismissing because they sound unconventional. But a striking biological rationale and a large bibliography are not substitutes for well-controlled clinical evidence. The relevant question is not whether vitamin C has physiological roles, which it does, but whether a specific dose, route, and schedule reliably changes outcomes for a particular disease. Those are separate claims, and the book often treats them as one.

Treat Klenner's 60 polio recoveries as a signal, not proof

The defining case series. During a 1948 polio outbreak, physician Frederick Klenner reported treating 60 patients with vitamin C. He said all recovered without the residual paralysis often associated with polio. Some diagnoses were supported by spinal-fluid tests or contact with confirmed cases, while others rested on the clinical picture of an outbreak. Klenner described repeated injections, followed by less frequent dosing as fever and symptoms improved. His 1949 report and address to the American Medical Association are the book's dramatic opening evidence.

What the report cannot show. The series had no comparison group, and the cases were not all confirmed in the same way. It cannot establish how many patients would have recovered without vitamin C, whether the treatment prevented paralysis, or which component of care mattered. The account is historically notable and generates a research question, but it does not prove a cure.

Analysis

Klenner's report has the narrative force of a breakthrough that medicine overlooked. Its evidential force is more limited. In an outbreak, clinicians can identify genuine patterns, but retrospective case series are vulnerable to diagnostic uncertainty, selective reporting, and the natural course of disease. A particularly impressive outcome should prompt replication, not exemption from it. The distinction matters because readers can respect Klenner's clinical observations while still asking for prospective comparisons, consistent diagnostic criteria, and outcomes assessed by people who do not know which treatment patients received.

Dose, timing, and route are central to Levy's treatment model

More than a vitamin dose. Levy argues that studies using small supplements cannot fairly test a therapy he believes requires much more vitamin C. Klenner's 1949 remarks proposed 6 to 20 grams over a day for polio, while his case reports describe varying schedules and injection routes. Levy distinguishes ordinary nutritional amounts from what he calls an optidose, meaning the amount he considers optimal for a person's current condition. He also draws on Robert Cathcart's bowel tolerance method, which uses the point at which oral vitamin C causes loose stools as a rough indicator of how much the body is absorbing or using.

A methodological issue, not a prescription. Dose and delivery are legitimate variables in treatment research. They do not establish that larger doses are more effective or safe for every patient. The book's proposed regimens are historical claims, not do-it-yourself instructions. Acute infections and poisonings require professional diagnosis and established urgent care.

Analysis

The dose argument identifies a real weakness in research design: a negative result at one dose does not automatically answer what another dose would do. Yet this logic can become unfalsifiable if every failure is explained as too little treatment, with no prespecified ceiling or stopping rule. Bowel tolerance is also an indirect marker, not a direct measurement of tissue concentration or clinical benefit. Strong trials would compare defined doses and routes, monitor adverse effects, and specify in advance what counts as success.

Human inability to make vitamin C supports need, not megadose proof

A real biological difference. Humans, like other primates and guinea pigs, cannot make vitamin C internally because they lack functional activity of the liver enzyme L-gulonolactone oxidase, abbreviated GLO. Many other mammals can produce the nutrient, and the book contrasts humans with animals such as goats, which it says can increase production under stress. Levy argues that human dependence on food and supplements leaves people unusually vulnerable when infection or toxins increase demand.

Where the inference stretches. The book also presents Szent-Györgyi's idea that vitamin C helps sustain electron exchange in living tissue, then links impaired exchange to illness. This is a broad explanatory theory, not an established clinical model for deciding how much vitamin C a patient needs. The genetic inability to synthesize vitamin C explains why it must come from outside the body. It does not, by itself, demonstrate that high doses prevent or cure most disease.

Analysis

The missing enzyme is a compelling fact, but the leap from evolutionary difference to an optimal therapeutic dose is not automatic. A nutrient can be essential without higher intake producing steadily greater benefit. Vitamin C has well-established roles in collagen formation and redox chemistry, while the book's electron-flow account offers a much broader explanation than those specific functions support. The useful distinction is between a sound biological premise and a dose-response claim. The first deserves attention; the second needs direct clinical measurement.

Low vitamin C during illness may be consequence as well as cause

Depletion across diseases. Levy collects reports of reduced vitamin C in people with infections and other illnesses, including tuberculosis, hepatitis, and HIV. He interprets low blood or tissue levels, reduced urinary excretion, and bleeding symptoms as signs that disease processes consume vitamin C. In his account, severe infection can create a scurvy-like state even when the illness was not caused by a lack of vitamin C in the diet. He therefore treats supplementation as a general support for the body's response to illness.

Association cuts both ways. Low levels during disease do not reveal whether low vitamin C helped cause illness, whether illness lowered vitamin C, or whether both reflect another factor. The book often moves from depletion to a claim that supplementation will prevent or reverse disease. That conclusion needs intervention studies, not just measurements taken after people become sick.

Analysis

This is a useful caution against assuming that one normal blood measurement captures nutrient availability in every tissue or under every stress. It is also a classic problem in causal reasoning. Inflammation, poor intake, altered metabolism, and disease severity can all change measured nutrient levels. A low value may be a cause, a consequence, or both. To distinguish these possibilities, researchers need measurements before illness, during illness, and after controlled supplementation, along with meaningful clinical outcomes rather than biochemical changes alone.

A plausible antioxidant mechanism does not make vitamin C a universal antidote

The proposed mechanism. The book describes vitamin C as an antioxidant that can donate electrons, reduce oxidative stress, and, in some settings, support liver processes involved in detoxification. Levy also argues that vitamin C can neutralize toxins directly or help repair damage without binding the toxin itself. He brings together examples involving alcohol, pesticides, metals, radiation, venom, and drugs, drawing on animal experiments, laboratory studies, and human case reports.

The evidence varies sharply. Some results concern cells or animals, while others are individual clinical accounts. Those forms of evidence cannot establish that vitamin C is an effective antidote for every human poisoning. Poison-specific treatment matters, and the book's broad use of the word antidote risks obscuring differences in mechanism, dose, and urgency. Its evidence supports investigating a possible adjunct role, not replacing established emergency treatment.

Analysis

Antioxidant chemistry provides a credible reason to study protection from oxidative injury, but it does not imply one antioxidant can neutralize chemically unrelated poisons in people. A toxin may require removal, a specific binding agent, respiratory support, or another intervention that vitamin C cannot provide. Even when an animal model shows protection, differences in exposure and metabolism complicate translation. The strongest interpretation is that vitamin C may have useful context-dependent effects. The weakest is the universal-antidote conclusion, which collapses distinct toxicology problems into one solution.

Question medical gatekeeping without confusing old case reports for trials

The institutional critique. Levy argues that medical training, textbooks, professional conformity, and fear of ridicule can keep clinicians from reconsidering older findings. He illustrates the point with the ketogenic diet, an established epilepsy treatment that a fictionalized television story depicts doctors dismissing before a child's seizures improve. He says Klenner's polio claims met a similar wall of indifference after his 1949 presentation to the AMA.

An important boundary. The book also claims that vitamin C could make vaccinations unnecessary and avoid their harms. The case reports and laboratory studies presented do not establish that conclusion. Criticism of professional inertia is not evidence that a therapy works, just as an unconventional treatment's exclusion from textbooks does not prove it is wrong. Readers should not substitute vitamin C for vaccination, antibiotics, or emergency care on the basis of this book.

Analysis

Medical communities can be slow to absorb evidence, especially when a treatment is old, inexpensive, or outside familiar practice. The ketogenic-diet story makes that social mechanism vivid. But scientific skepticism is not identical to social conformity. A useful safeguard is to ask whether criticism addresses data quality or merely the source, and whether advocacy applies the same standard to positive and negative findings. That discipline protects promising ideas from premature dismissal and patients from claims that outpace the evidence.

Safety claims need exceptions: kidneys, G6PD, iron, and dehydration matter

A favorable record with limits. Levy cites experience with large oral and intravenous amounts and reports that serious problems are uncommon. He describes diarrhea and stomach upset as dose-related effects of oral use. He also discusses kidney stone concerns, arguing that large studies in healthy adults did not find vitamin C intake increased stone risk. But he notes reports of oxalate-related kidney injury, particularly in people with existing kidney disease, and reports of red-cell breakdown in people with G6PD deficiency. Iron overload and dehydration are additional concerns in the book.

Do not infer zero risk. The source's broad reassurance sits beside rare but serious complications and limited evidence for many proposed uses. High-dose intravenous treatment also requires clinical oversight. These cautions are not a complete safety protocol, and no reader should use the book's dosing advice to treat poisoning or infection without qualified medical care.

Analysis

Safety is a property of a dose in a particular patient, not a permanent label attached to a molecule. The book is right to distinguish healthy adults from people with impaired kidney function or particular blood disorders, but its reassuring tone can underplay how difficult rare harms are to quantify. Case reports cannot establish incidence, while an absence of reported harm is not proof of safety. Clinicians can reduce uncertainty through screening, medication review, hydration assessment, and monitoring tailored to the patient.

Liposomes may improve delivery, but their claimed edge over IV remains unproven

A delivery technology. A liposome is a tiny phospholipid sphere that can carry water-soluble substances. The book explains that its membrane resembles cell membranes and proposes that encapsulated vitamin C can survive digestion, enter the bloodstream, and reach cells more effectively than ordinary oral supplements. Levy argues that this route may even outperform intravenous vitamin C for intracellular delivery, and recommends combining oral liposomal and intravenous forms when both are available.

Promise is not proof. Liposomes are a genuine drug-delivery technology, but the book's claims about vitamin C superiority rely on limited pharmacokinetic and clinical evidence. Different formulations may behave differently, and blood levels do not alone establish improved health outcomes. The technology is a plausible research direction, not a reason to assume that a commercial product cures infections or replaces standard care.

Analysis

The distinction between concentration in blood and delivery into cells is scientifically important. A carrier that changes absorption could alter both efficacy and side effects, which makes formulation research worthwhile. Still, claims of superiority require independent, head-to-head trials measuring more than blood concentrations. They need to compare standardized products, dose, tolerability, and patient outcomes. Without that evidence, liposomal delivery is best understood as a promising platform whose clinical advantages remain uncertain, not as a demonstrated upgrade over intravenous treatment.

Analysis

Curing the Incurable is an advocacy work built around a neglected-clinician narrative. Frederick Klenner supplies the human drama: a country doctor reports rapid recoveries during epidemics, presents his results to professional peers, and is not embraced. Levy then turns that story into a broad thesis, arguing that vitamin C can treat infections and neutralize toxins when given in large enough amounts. The organization reinforces this case by moving from biology, to disease-by-disease reports, to toxicology, safety, delivery technology, and practical dosing.

The book's strongest contribution is its insistence that dose, route, and treatment timing belong in the research question. A small oral supplement cannot answer whether a much larger intravenous dose has an effect. Its exhaustive reference gathering also makes obscure studies easier to find. But the central weakness is the repeated conversion of possibility into certainty. Klenner's uncontrolled case series, animal models, and test-tube experiments are presented alongside language of cure, even though each evidence type answers a different question. For illnesses that can resolve spontaneously or require urgent treatment, this distinction is consequential.

The text also blurs several claims: that humans need vitamin C from diet, that illness can lower measured vitamin C, that high doses alter laboratory markers, and that high-dose treatment cures disease. Each can be investigated separately, but none logically proves the next. The same problem affects its broad claim that vitamin C could displace vaccination or standard treatment. That is not supported by the evidence assembled.

A fair reading preserves the book's research prompt while resisting its certainty. The testable question is not whether vitamin C is important, but which disease, formulation, dose, route, timing, and patient group show meaningful benefit compared with appropriate care. Carefully controlled trials, transparent adverse-event monitoring, and independent replication would turn a large historical archive into reliable clinical guidance. Until then, the book is best read as a forceful hypothesis and history of medical dissent, not as a treatment manual.

Summary in 30 Seconds
Thomas Levy presents high-dose vitamin C as a possible treatment for infections and poisoning, drawing heavily on clinician Frederick Klenner's report of 60 polio patients who recovered. That uncontrolled case series cannot establish that vitamin C caused recovery or prevented paralysis. Dose, timing, and delivery route matter for testing the claim, but larger doses are not proven more effective. Illness-related low vitamin C may be a consequence rather than a cause, and serious safety risks exist for some patients. The evidence supports further trials, not replacing standard care.
Contains spoilers

Last updated:

Report Issue

Review Summary

4.39 out of 5
Average of 158 ratings from Goodreads and Amazon.

Curing the Incurable receives mostly positive reviews for its comprehensive analysis of vitamin C's benefits. Readers praise its scientific depth and extensive references, though some find it technical and biased. Many appreciate the book's insights on high-dose vitamin C for treating various diseases and neutralizing toxins. Criticisms include its repetitive nature and lack of practical advice for average users. Several readers report personal success with vitamin C supplementation. The book is seen as valuable for those interested in alternative health approaches, despite its challenging content for laypeople.

Your rating:
4.63
123 ratings
Want to read the full book?

Glossary

optidosing

Author's proposed optimal dosing

Levy's term for adjusting vitamin C intake to what he considers the amount needed at a given time. He argues that needs vary with illness, toxin exposure, and the individual, and distinguishes an optidose from a large dose that may still be inadequate. It is the author's proposed approach, not a validated dosing standard.

bowel tolerance

Oral dose before diarrhea

A dose-adjustment method associated in the book with physician Robert Cathcart. Oral vitamin C is increased until loose stools or diarrhea occur, which the method treats as a rough sign that more vitamin C is reaching the lower bowel than the body is absorbing or using. Levy uses this response as a guide to individual dosing, though it does not directly measure tissue levels or treatment benefit.

L-gulonolactone oxidase (GLO)

Enzyme needed to make vitamin C

The final enzyme in a pathway that converts glucose into vitamin C in many animals. Levy notes that humans and some other species lack functional GLO activity and therefore depend on dietary sources. He uses this genetic difference to argue for greater attention to vitamin C intake, while the further claim that it calls for very high therapeutic doses is not established by the enzyme fact alone.

crossover effect

Shift between oxidative effects

The term used in the book for a proposed shift in vitamin C's net effect depending on its concentration and the presence of catalytic metals such as iron or copper. In the cited chemical models, conditions can favor oxidative activity at one concentration and antioxidant activity at another. The book argues that this effect is uncommon in ordinary physiology and that higher vitamin C amounts may favor antioxidant action.

liposome

Phospholipid delivery sphere

A microscopic sphere made from phospholipids, with a membrane that can enclose water-soluble substances. The book describes liposomes as carriers intended to protect a nutrient or drug during absorption and help deliver it into cells. Their properties depend on formulation, and the book's claim that oral liposomal vitamin C can outperform intravenous vitamin C is presented as a developing clinical proposition, not an established general result.

About the Author

Thomas E. Levy is a cardiologist and lawyer who has authored multiple books on vitamin C and its health benefits. His work in "Curing the Incurable" draws from over 1,200 scientific references, demonstrating his extensive research on the subject. Levy's approach combines medical expertise with legal training, allowing him to present complex scientific information in an accessible manner. He is known for advocating high-dose vitamin C therapy and has contributed significantly to the field of nutritional medicine. Levy's work builds upon the foundations laid by earlier vitamin C researchers, and he is particularly interested in the potential of liposomal vitamin C delivery methods.

Download PDF

To save this Curing the Incurable summary for later, download the free PDF. You can print it out, or read offline at your convenience.
Download PDF
File size: 0.29 MB     Pages: 15

Download EPUB

To read this Curing the Incurable summary on your e-reader device or app, download the free EPUB. The .epub digital book format is ideal for reading ebooks on phones, tablets, and e-readers.
Download EPUB
File size: 1.35 MB     Pages: 19
Want to read the full book?
Follow
Listen
Home
Swipe
Library
Get App
Try Full Access for 3 Days
Listen, bookmark, and more
Compare Features Free Pro
📖 Read Summaries
Read unlimited summaries. Free users get 3 per month
🎧 Listen to Summaries
Listen to unlimited summaries in 40 languages
—
❤️ Unlimited Bookmarks
Free users are limited to 4
—
📜 Unlimited History
Free users are limited to 4
—
📥 Unlimited Downloads
Free users are limited to 1
—
Risk-Free Timeline
Today: Get Instant Access
Listen to full summaries of 26,000+ books. That's 12,000+ hours of audio!
Day 2: Trial Reminder
We'll send you a notification that your trial is ending soon.
Day 3: Your subscription begins
You'll be charged on Nov 24,
cancel anytime before.
Consume 2.8× More Books
2.8× more books Listening Reading
Our users love us
1M+ readers
Trustpilot Rating
TrustPilot
4.6 Excellent
This site is a total game-changer. I've been flying through book summaries like never before. Highly, highly recommend.
— Dave G
Worth my money and time, and really well made. I've never seen this quality of summaries on other websites. Very helpful!
— Em
Highly recommended!! Fantastic service. Perfect for those that want a little more than a teaser but not all the intricate details of a full audio book.
— Greg M
Save 62%
Yearly
$119.88 $44.99/year/yr
$3.75/mo
Monthly
$9.99/mo
Start a 3-Day Free Trial
3 days free, then $44.99/year. Cancel anytime.
Unlock a world of fiction & nonfiction books
26,000+ books for the price of 2 books
Read any book in 10 minutes
Discover new books like Tinder
Request any book if it's not summarized
Read more books than anyone you know
#1 app for book lovers
Lifelike & immersive summaries
30-day money-back guarantee
Download summaries in EPUBs or PDFs
Cancel anytime in a few clicks

Why one summary?

Scanner
Find a barcode to scan

⭐
⭐
⭐
We have a special gift for you
Open
38% off
DISCOUNT FOR YOU
⭐
⭐
⭐
$79.99
$49.99/year
Only $4.16 per month
Continue
2 taps to start, super easy to cancel
Settings
General
Widget
Loading...